Skip to main content
Caplight Logo









Bioceltech Therapeutics, Ltd.

Bioceltech Therapeutics, Ltd.

Private
BeijingHealthcare & Life Scienceshttp://bioceltech.com/

Last Round

Series A

Jun 2, 2023

Total Funding Raised

$8M

Company Overview

Bioceltech Therapeutics, Ltd. is a biotechnology company that focuses on the development and application of immunotherapy, including CAR-T cell therapies for the treatment of hematologic neoplasms and solid tumors.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

cell therapyCAR-Tregenerative medicinebiopharmaceutical R&Dclinical trialsimmunotherapygene engineeringbiotech startupimmune function inspectionclinical-stage biotechcell-based therapyadvanced therapies

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Bioceltech Therapeutics, Ltd. Comparables

Compare Bioceltech Therapeutics, Ltd. with similar companies based on industry and business-model similarity.

Bioceltech Therapeutics, Ltd. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Sichuan Neo-Immunotech Co., Ltd.
79%
Juventas Cell Therapy Ltd.
79%
AbelZeta Pharma
78%

Bioceltech Therapeutics, Ltd. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AJun 2, 2023
AngelJan 4, 2018

Bioceltech Therapeutics, Ltd. Investors

Notable investors and investment history

Bioceltech Therapeutics, Ltd. investors
InvestorRounds
CanicaSeries A
SandwaterSeries A
Anlong FundAngel

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 2, 2023

    Raised $8M with participation from Canica and Sandwater.

  • Jan 4, 2018

    Anlong Fund participated in the Angel round.

Bioceltech Therapeutics, Ltd. Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Bioceltech Therapeutics, Ltd. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Bioceltech Therapeutics, Ltd.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersBeijing
Year Founded2017
Last FundingJun 2, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?